Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Opinion in Infectious Diseases|August 19, 2010
Influenza in travellersHelena H Askling, Lars RomboTravel Medicine and Infectious Disease|May 14, 2014
The medically immunocompromised adult traveler and pre-travel counseling: status quo 2014Helena H Askling, Virgil A S H DalmMilitary Medicine|January 20, 2009
Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006Håkan Andersson, Helena H Askling, Björn Falck, et al.Journal of Internal Medicine|July 10, 2023
Sociodemographic disparities affect COVID-19 vaccine uptake in non-elderly adults with increased risk of severe COVID-19Pontus Hedberg, Adonis Sotoodeh, Helena H Askling, et al.Journal of Travel Medicine|August 14, 2009
Hepatitis A risk in travelersHelena H Askling, Lars Rombo, Yvonne Andersson, et al.Travel Medicine and Infectious Disease|December 13, 2017
An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression - A prospective, open-label, multi-center studyAnja Rosdahl, Christian Herzog, Gert Frösner, et al.Vaccine|January 1, 2016
Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre studyKatarina Brodin Hertzell, Karlis Pauksens, Lars Rombo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2019
Tick-borne Encephalitis Vaccine Failures: A 10-year Retrospective Study Supporting the Rationale for Adding an Extra Priming Dose in Individuals Starting at Age 50 YearsKarin E Hansson, Anja Rosdahl, Mona Insulander, et al.Travel Medicine and Infectious Disease|February 18, 2014
Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre studyHelena H Askling, Lars Rombo, Ronald van Vollenhoven, et al.Travel Medicine and Infectious Disease|June 4, 2023
Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?Martin Angelin, Jan Sjölin, Fredrik Kahn, et al.Pageof 3